{
    "clinical_study": {
        "@rank": "82227", 
        "arm_group": {
            "arm_group_label": "Peritoneal Mesotheliomas", 
            "description": "Cytoreductive surgery and HIPEC"
        }, 
        "brief_summary": {
            "textblock": "Review of the investigators hospital experience in cytoreductive surgery and hyperthermic\n      intra-peritoneal chemotherapy (HIPEC) for peritoneal mesotheliomas, using Oxaliplatin as\n      intraperitoneal chemotherapeutic agent."
        }, 
        "brief_title": "Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Peritoneal Mesotheliomas", 
        "condition_browse": {
            "mesh_term": [
                "Fever", 
                "Mesothelioma"
            ]
        }, 
        "detailed_description": {
            "textblock": "Observation of primary outcome:\n\n        -  Overall Survival\n\n        -  Disease-free survival\n\n      Influencing factors that will be observe:\n\n        -  Sex\n\n        -  Blood loss\n\n        -  Time of surgery\n\n        -  Number of resection and anastomosis\n\n        -  Peritoneal Index (PI score)\n\n        -  Cytoreductibility (CCR score)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Peritoneal mesothelioma\n\n        Exclusion Criteria:\n\n          -  Non resectable disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients suffering of peritoneal mesotheliomas undergoing cytoreductive surgery and HIPEC"
            }
        }, 
        "enrollment": {
            "#text": "19", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01812148", 
            "org_study_id": "Maisonneuve Rosemont Hospital", 
            "secondary_id": "12112"
        }, 
        "intervention": {
            "arm_group_label": "Peritoneal Mesotheliomas", 
            "description": "Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) with Oxaliplatin as chemotherapeutic agent", 
            "intervention_name": "Cytoreductive surgery and HIPEC", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": "Oxaliplatin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Peritoneal Mesotheliomas", 
            "hyperthermic intra-peritoneal chemotherapy (HIPEC)", 
            "Oxaliplatin", 
            "Cytoreductive surgery", 
            "Oxaliplatin HIPEC"
        ], 
        "lastchanged_date": "March 15, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Montr\u00e9al", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H1T 2M4"
                }, 
                "name": "Maisonneuve Rosemont Hospital"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "official_title": "Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)", 
        "overall_official": {
            "affiliation": "Maisonneuve-Rosemont Hospital", 
            "last_name": "Lucas Sideris, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Overall survival", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01812148"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Maisonneuve-Rosemont Hospital", 
            "investigator_full_name": "Julien Hubert", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Disease-Free survival", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "source": "Maisonneuve-Rosemont Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Maisonneuve-Rosemont Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Case-Crossover, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}